Global Antacids Market By Type, By End-Use, By Region & Segmental Insights Trends and Forecast, 2023 – 2031

  • Industry: Healthcare
  • Report ID: TNR-110-1030
  • Number of Pages: 420
  • Table/Charts : Yes
  • November, 2023
  • Base Year : 2024
  • No. of Companies : 11+
  • No. of Countries : 29
  • Views : 10076
  • Covid Impact Covered: Yes
  • War Impact Covered: Yes
  • Formats : PDF, Excel, PPT

Antacids are over-the-counter medications that help relieve heartburn, acid indigestion, and upset stomach by neutralizing excess stomach acid. They contain compounds like calcium carbonate or magnesium hydroxide, which react with gastric acid to form water and salt, reducing acidity and providing temporary relief from digestive discomfort. In terms of revenue, the global antacids market was worth US$ 6.48 Bn in 2022, anticipated to witness CAGR of 3.5% during 2023 – 2031.

Global Antacids Market Revenue & Forecast, (US$ Million), 2015 – 2031

Trends in the Global Antacids Market

  • Presently, there is an increasing trend in health-conscious individuals seeking natural and non-pharmaceutical solutions for digestive issues. Consumers are continuously prioritizing healthy lifestyles and sustainable alternatives. Consequently, this trend is driving the antacids market towards the development of more organic and plant-based antacid options, emphasizing ingredients like ginger and aloe vera, which are perceived as gentler on the stomach.
  • The antacids market is experiencing a surge in online sales. With the current global shift towards digitalization, consumers are increasingly purchasing healthcare products, including antacids, online. This trend is fueled by convenience, accessibility, and the availability of a wide range of products. As a result, companies in the antacids market are optimizing their online presence, engaging in e-commerce partnerships, and enhancing user experience through intuitive websites and mobile apps to cater to this growing demand.

Liquid segment has gained popularity in recent years and is anticipated to be the fastest growing segment in the global antacids market during the forecast period. This is due to its ease of consumption and fast-acting nature. This segment has witnessed a substantial increase in sales volume, with a notable surge in demand, particularly among the elderly population. Liquid antacids are preferred by a growing number of consumers seeking immediate relief from digestive discomfort. This preference is reflected in the significant increase in production and distribution of liquid antacid products in recent years, with sales reaching billions of units annually. The liquid segment’s appeal lies in its quick effectiveness and suitability for various age groups.

Retail pharmacy end-use segment had the highest share in the global antacids market in 2022. This can be attributed to its extensive accessibility and widespread presence. Retail pharmacies serve as a convenient one-stop destination for consumers seeking over-the-counter healthcare products, including antacids. Their extensive networks ensure that consumers have easy access to antacids in urban and rural areas alike. Furthermore, consumers often trust the reliability and quality of products available at these established pharmacies. This trust and accessibility have led to a substantial market share for the retail pharmacy segment. Consumer footfall and consistent demand contribute to their continued dominance in the antacids market.

Asia Pacific is expected to witness the highest growth rate in the antacids market during the forecast period. In the region, the incidence of acid-related conditions, such as gastroesophageal reflux disease (GERD), has been steadily increasing, with millions of reported cases annually. Furthermore, the aging population in this region is projected to reach hundreds of millions by 2030, contributing to a higher demand for antacids. The online sales of healthcare products in Asia Pacific have witnessed a substantial surge, accounting for a significant portion of antacid purchases. For instance, the online pharmacy market in the region has experienced rapid growth, with billions of dollars in annual sales. These statistics reflect the region’s robust demand for antacids and its evolving healthcare landscape.

Competitive Landscape: Global Antacids Market

  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Dr. Reddy’s Laboratories Ltd.
  • GSK plc
  • Pfizer Inc.
  • Procter & Gamble
  • Reckitt Benckiser Group PLC
  • Sanofi
  • Sun Pharmaceutical Industries Ltd.
  • Takeda Pharmaceutical Company Limited
  • Other Industry Participants

Global Antacids Market Scope

Report Specifications Details
Market Revenue in 2022 US$ 6.48 Bn
Market Size Forecast by 2031 US$ 9.45 Bn
Growth Rate (CAGR) 3.5%
Historic Data 2015 – 2021
Base Year for Estimation 2022
Forecast Period 2023 – 2031
Report Inclusions Market Size & Estimates, Market Dynamics, Competitive Scenario, Trends, Growth Factors, Market Determinants, Key Investment Segmentation, Product/Service/Solutions Benchmarking
Segments Covered By Type, By End-Use
Regions Covered North America, Europe, Asia Pacific, Middle East & Africa, Latin America
Countries Covered U.S., Canada, Mexico, Rest of North America,  France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe,  China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific,  Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa,  Brazil, Argentina, Rest of Latin America
Key Players Bayer AG, Boehringer Ingelheim International GmbH, Dr. Reddy’s Laboratories Ltd., GSK plc, Pfizer Inc., Procter & Gamble, Reckitt Benckiser Group PLC, Sanofi, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Other market participants
Customization Scope Customization allows for the inclusion/modification of content pertaining to geographical regions, countries, and specific market segments.
Pricing & Procurement Options Explore purchase options tailored to your specific research requirements
Contact Details Consult With Our Expert

Japan (Toll-Free):  +81 663-386-8111

South Korea (Toll-Free):  +82-808- 703-126

Saudi Arabia (Toll-Free):  +966 800-850-1643

United Kingdom: +44 753-710-5080

United States: +1 302-232-5106

E-mail:  askanexpert@thenicheresearch.com

 

Global Antacids Market

By Type

  • Tablet
  • Liquid
  • Others

By End-use

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

By Region

  • North America (U.S., Canada, Mexico, Rest of North America)
  • Europe (France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe)
  • Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific)
  • Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa)
  • Latin America (Brazil, Argentina, Rest of Latin America)

Report Coverage & Deliverables

 

Table of Contents

.

1.Market Scope
1.1.Market Segmentation
1.2.Years Considered
1.2.1.Historic Years: 2015 – 2021
1.2.2.Base Year: 2022
1.2.3.Forecast Years: 2023 – 2031
2.Key Target Audiences
3.Research Methodology
3.1.Primary Research
3.1.1.Research Questionnaire
3.1.2.Global Percentage Breakdown
3.1.3.Primary Interviews: Key Opinion Leaders (KOLs)
3.2.Secondary Research
3.2.1.Paid Databases
3.2.2.Secondary Sources
3.3.Market Size Estimates
3.3.1.Top-Down Approach
3.3.2.Bottom-Up Approach
3.4.Data Triangulation Methodology
3.5.Research Assumptions
4.Recommendations and Insights from TNR’s Perspective**
5.Holistic Overview of Antacids Market
6.Market Synopsis: Antacids Market
7.Antacids Market Analysis: Qualitative Perspective
7.1.Introduction
7.1.1.Product Definition
7.1.2.Industry Development
7.2.Market Dynamics
7.2.1.Drivers
7.2.2.Restraints
7.2.3.Opportunities
7.2.4.Challenges
7.3.Trends in Antacids Market
7.4.Market Determinants Radar Chart
7.5.Macro-Economic and Micro-Economic Indicators: Antacids Market
7.6.Porter’s Five Force Analysis
7.7.Impact of Covid-19 on Antacids Market
8.Global Antacids Market Analysis and Forecasts, 2023 – 2031
8.1.Overview
8.1.1.Global Antacids Market Revenue (US$ Mn)
8.2.Global Antacids Market Revenue (US$ Mn) and Forecasts, By Type
8.2.1.Tablet
8.2.1.1.Definition
8.2.1.2.Market Estimation and Penetration, 2015 – 2022
8.2.1.3.Market Forecast, 2023 – 2031
8.2.1.4.Compound Annual Growth Rate (CAGR)
8.2.1.5.Regional Bifurcation
8.2.1.5.1.North America
8.2.1.5.1.1.Market Estimation, 2015 – 2022
8.2.1.5.1.2.Market Forecast, 2023 – 2031
8.2.1.5.2.Europe
8.2.1.5.2.1.Market Estimation, 2015 – 2022
8.2.1.5.2.2.Market Forecast, 2023 – 2031
8.2.1.5.3.Asia Pacific
8.2.1.5.3.1.Market Estimation, 2015 – 2022
8.2.1.5.3.2.Market Forecast, 2023 – 2031
8.2.1.5.4.Middle East and Africa
8.2.1.5.4.1.Market Estimation, 2015 – 2022
8.2.1.5.4.2.Market Forecast, 2023 – 2031
8.2.1.5.5.Latin America
8.2.1.5.5.1.Market Estimation, 2015 – 2022
8.2.1.5.5.2.Market Forecast, 2023 – 2031
8.2.2.Liquid
8.2.2.1.Definition
8.2.2.2.Market Estimation and Penetration, 2015 – 2022
8.2.2.3.Market Forecast, 2023 – 2031
8.2.2.4.Compound Annual Growth Rate (CAGR)
8.2.2.5.Regional Bifurcation
8.2.2.5.1.North America
8.2.2.5.1.1.Market Estimation, 2015 – 2022
8.2.2.5.1.2.Market Forecast, 2023 – 2031
8.2.2.5.2.Europe
8.2.2.5.2.1.Market Estimation, 2015 – 2022
8.2.2.5.2.2.Market Forecast, 2023 – 2031
8.2.2.5.3.Asia Pacific
8.2.2.5.3.1.Market Estimation, 2015 – 2022
8.2.2.5.3.2.Market Forecast, 2023 – 2031
8.2.2.5.4.Middle East and Africa
8.2.2.5.4.1.Market Estimation, 2015 – 2022
8.2.2.5.4.2.Market Forecast, 2023 – 2031
8.2.2.5.5.Latin America
8.2.2.5.5.1.Market Estimation, 2015 – 2022
8.2.2.5.5.2.Market Forecast, 2023 – 2031
8.2.3.Others
8.2.3.1.Definition
8.2.3.2.Market Estimation and Penetration, 2015 – 2022
8.2.3.3.Market Forecast, 2023 – 2031
8.2.3.4.Compound Annual Growth Rate (CAGR)
8.2.3.5.Regional Bifurcation
8.2.3.5.1.North America
8.2.3.5.1.1.Market Estimation, 2015 – 2022
8.2.3.5.1.2.Market Forecast, 2023 – 2031
8.2.3.5.2.Europe
8.2.3.5.2.1.Market Estimation, 2015 – 2022
8.2.3.5.2.2.Market Forecast, 2023 – 2031
8.2.3.5.3.Asia Pacific
8.2.3.5.3.1.Market Estimation, 2015 – 2022
8.2.3.5.3.2.Market Forecast, 2023 – 2031
8.2.3.5.4.Middle East and Africa
8.2.3.5.4.1.Market Estimation, 2015 – 2022
8.2.3.5.4.2.Market Forecast, 2023 – 2031
8.2.3.5.5.Latin America
8.2.3.5.5.1.Market Estimation, 2015 – 2022
8.2.3.5.5.2.Market Forecast, 2023 – 2031
8.3.Key Segment for Channeling Investments
8.3.1.By Type
9.Global Antacids Market Analysis and Forecasts, 2023 – 2031
9.1.Overview
9.2.Global Antacids Market Revenue (US$ Mn) and Forecasts, By End-use
9.2.1.Hospital Pharmacy
9.2.1.1.Definition
9.2.1.2.Market Estimation and Penetration, 2015 – 2022
9.2.1.3.Market Forecast, 2023 – 2031
9.2.1.4.Compound Annual Growth Rate (CAGR)
9.2.1.5.Regional Bifurcation
9.2.1.5.1.North America
9.2.1.5.1.1.Market Estimation, 2015 – 2022
9.2.1.5.1.2.Market Forecast, 2023 – 2031
9.2.1.5.2.Europe
9.2.1.5.2.1.Market Estimation, 2015 – 2022
9.2.1.5.2.2.Market Forecast, 2023 – 2031
9.2.1.5.3.Asia Pacific
9.2.1.5.3.1.Market Estimation, 2015 – 2022
9.2.1.5.3.2.Market Forecast, 2023 – 2031
9.2.1.5.4.Middle East and Africa
9.2.1.5.4.1.Market Estimation, 2015 – 2022
9.2.1.5.4.2.Market Forecast, 2023 – 2031
9.2.1.5.5.Latin America
9.2.1.5.5.1.Market Estimation, 2015 – 2022
9.2.1.5.5.2.Market Forecast, 2023 – 2031
9.2.2.Retail Pharmacy
9.2.2.1.Definition
9.2.2.2.Market Estimation and Penetration, 2015 – 2022
9.2.2.3.Market Forecast, 2023 – 2031
9.2.2.4.Compound Annual Growth Rate (CAGR)
9.2.2.5.Regional Bifurcation
9.2.2.5.1.North America
9.2.2.5.1.1.Market Estimation, 2015 – 2022
9.2.2.5.1.2.Market Forecast, 2023 – 2031
9.2.2.5.2.Europe
9.2.2.5.2.1.Market Estimation, 2015 – 2022
9.2.2.5.2.2.Market Forecast, 2023 – 2031
9.2.2.5.3.Asia Pacific
9.2.2.5.3.1.Market Estimation, 2015 – 2022
9.2.2.5.3.2.Market Forecast, 2023 – 2031
9.2.2.5.4.Middle East and Africa
9.2.2.5.4.1.Market Estimation, 2015 – 2022
9.2.2.5.4.2.Market Forecast, 2023 – 2031
9.2.2.5.5.Latin America
9.2.2.5.5.1.Market Estimation, 2015 – 2022
9.2.2.5.5.2.Market Forecast, 2023 – 2031
9.2.3.Online Pharmacy
9.2.3.1.Definition
9.2.3.2.Market Estimation and Penetration, 2015 – 2022
9.2.3.3.Market Forecast, 2023 – 2031
9.2.3.4.Compound Annual Growth Rate (CAGR)
9.2.3.5.Regional Bifurcation
9.2.3.5.1.North America
9.2.3.5.1.1.Market Estimation, 2015 – 2022
9.2.3.5.1.2.Market Forecast, 2023 – 2031
9.2.3.5.2.Europe
9.2.3.5.2.1.Market Estimation, 2015 – 2022
9.2.3.5.2.2.Market Forecast, 2023 – 2031
9.2.3.5.3.Asia Pacific
9.2.3.5.3.1.Market Estimation, 2015 – 2022
9.2.3.5.3.2.Market Forecast, 2023 – 2031
9.2.3.5.4.Middle East and Africa
9.2.3.5.4.1.Market Estimation, 2015 – 2022
9.2.3.5.4.2.Market Forecast, 2023 – 2031
9.2.3.5.5.Latin America
9.2.3.5.5.1.Market Estimation, 2015 – 2022
9.2.3.5.5.2.Market Forecast, 2023 – 2031
9.3.Key Segment for Channeling Investments
9.3.1.By End-use
10.North America Antacids Market Analysis and Forecasts, 2023 – 2031
10.1.Overview
10.1.1.North America Antacids Market Revenue (US$ Mn)
10.2.North America Antacids Market Revenue (US$ Mn) and Forecasts, By Type
10.2.1.Tablet
10.2.2.Liquid
10.2.3.Others
10.3.North America Antacids Market Revenue (US$ Mn) and Forecasts, By End-use
10.3.1.Hospital Pharmacy
10.3.2.Retail Pharmacy
10.3.3.Online Pharmacy
10.4.North America Antacids Market Revenue (US$ Mn) and Forecasts, By Country
10.4.1.U.S
10.4.1.1.U.S Antacids Market Revenue (US$ Mn) and Forecasts, By Type
10.4.1.1.1.Tablet
10.4.1.1.2.Liquid
10.4.1.1.3.Others
10.4.1.2.U.S Antacids Market Revenue (US$ Mn) and Forecasts, By End-use
10.4.1.2.1.Hospital Pharmacy
10.4.1.2.2.Retail Pharmacy
10.4.1.2.3.Online Pharmacy
10.4.2.Canada
10.4.2.1.Canada Antacids Market Revenue (US$ Mn) and Forecasts, By Type
10.4.2.1.1.Tablet
10.4.2.1.2.Liquid
10.4.2.1.3.Others
10.4.2.2.Canada Antacids Market Revenue (US$ Mn) and Forecasts, By End-use
10.4.2.2.1.Hospital Pharmacy
10.4.2.2.2.Retail Pharmacy
10.4.2.2.3.Online Pharmacy
10.4.3.Mexico
10.4.3.1.Mexico Antacids Market Revenue (US$ Mn) and Forecasts, By Type
10.4.3.1.1.Tablet
10.4.3.1.2.Liquid
10.4.3.1.3.Others
10.4.3.2.Mexico Antacids Market Revenue (US$ Mn) and Forecasts, By End-use
10.4.3.2.1.Hospital Pharmacy
10.4.3.2.2.Retail Pharmacy
10.4.3.2.3.Online Pharmacy
10.4.4.Rest of North America
10.4.4.1.Rest of North America Antacids Market Revenue (US$ Mn) and Forecasts, By Type
10.4.4.1.1.Tablet
10.4.4.1.2.Liquid
10.4.4.1.3.Others
10.4.4.2.Rest of North America Antacids Market Revenue (US$ Mn) and Forecasts, By End-use
10.4.4.2.1.Hospital Pharmacy
10.4.4.2.2.Retail Pharmacy
10.4.4.2.3.Online Pharmacy
10.5.Key Segment for Channeling Investments
10.5.1.By Country
10.5.2.By Type
10.5.3.By End-use
11.Europe Antacids Market Analysis and Forecasts, 2023 – 2031
11.1.Overview
11.1.1.Europe Antacids Market Revenue (US$ Mn)
11.2.Europe Antacids Market Revenue (US$ Mn) and Forecasts, By Type
11.2.1.Tablet
11.2.2.Liquid
11.2.3.Others
11.3.Europe Antacids Market Revenue (US$ Mn) and Forecasts, By End-use
11.3.1.Hospital Pharmacy
11.3.2.Retail Pharmacy
11.3.3.Online Pharmacy
11.4.Europe Antacids Market Revenue (US$ Mn) and Forecasts, By Country
11.4.1.France
11.4.1.1.France Antacids Market Revenue (US$ Mn) and Forecasts, By Type
11.4.1.1.1.Tablet
11.4.1.1.2.Liquid
11.4.1.1.3.Others
11.4.1.2.France Antacids Market Revenue (US$ Mn) and Forecasts, By End-use
11.4.1.2.1.Hospital Pharmacy
11.4.1.2.2.Retail Pharmacy
11.4.1.2.3.Online Pharmacy
11.4.2.The UK
11.4.2.1.The UK Antacids Market Revenue (US$ Mn) and Forecasts, By Type
11.4.2.1.1.Tablet
11.4.2.1.2.Liquid
11.4.2.1.3.Others
11.4.2.2.The UK Antacids Market Revenue (US$ Mn) and Forecasts, By End-use
11.4.2.2.1.Hospital Pharmacy
11.4.2.2.2.Retail Pharmacy
11.4.2.2.3.Online Pharmacy
11.4.3.Spain
11.4.3.1.Spain Antacids Market Revenue (US$ Mn) and Forecasts, By Type
11.4.3.1.1.Tablet
11.4.3.1.2.Liquid
11.4.3.1.3.Others
11.4.3.2.Spain Antacids Market Revenue (US$ Mn) and Forecasts, By End-use
11.4.3.2.1.Hospital Pharmacy
11.4.3.2.2.Retail Pharmacy
11.4.3.2.3.Online Pharmacy
11.4.4.Germany
11.4.4.1.Germany Antacids Market Revenue (US$ Mn) and Forecasts, By Type
11.4.4.1.1.Tablet
11.4.4.1.2.Liquid
11.4.4.1.3.Others
11.4.4.2.Germany Antacids Market Revenue (US$ Mn) and Forecasts, By End-use
11.4.4.2.1.Hospital Pharmacy
11.4.4.2.2.Retail Pharmacy
11.4.4.2.3.Online Pharmacy
11.4.5.Italy
11.4.5.1.Italy Antacids Market Revenue (US$ Mn) and Forecasts, By Type
11.4.5.1.1.Tablet
11.4.5.1.2.Liquid
11.4.5.1.3.Others
11.4.5.2.Italy Antacids Market Revenue (US$ Mn) and Forecasts, By End-use
11.4.5.2.1.Hospital Pharmacy
11.4.5.2.2.Retail Pharmacy
11.4.5.2.3.Online Pharmacy
11.4.6.Nordic Countries
11.4.6.1.Nordic Countries Antacids Market Revenue (US$ Mn) and Forecasts, By Type
11.4.6.1.1.Tablet
11.4.6.1.2.Liquid
11.4.6.1.3.Others
11.4.6.2.Nordic Countries Antacids Market Revenue (US$ Mn) and Forecasts, By End-use
11.4.6.2.1.Hospital Pharmacy
11.4.6.2.2.Retail Pharmacy
11.4.6.2.3.Online Pharmacy
11.4.6.3.Nordic Countries Antacids Market Revenue (US$ Mn) and Forecasts, By Country
11.4.6.3.1.Denmark
11.4.6.3.2.Finland
11.4.6.3.3.Iceland
11.4.6.3.4.Sweden
11.4.6.3.5.Norway
11.4.7.Benelux Union
11.4.7.1.Benelux Union Antacids Market Revenue (US$ Mn) and Forecasts, By Type
11.4.7.1.1.Tablet
11.4.7.1.2.Liquid
11.4.7.1.3.Others
11.4.7.2.Benelux Union Antacids Market Revenue (US$ Mn) and Forecasts, By End-use
11.4.7.2.1.Hospital Pharmacy
11.4.7.2.2.Retail Pharmacy
11.4.7.2.3.Online Pharmacy
11.4.7.3.Benelux Union Antacids Market Revenue (US$ Mn) and Forecasts, By Country
11.4.7.3.1.Belgium
11.4.7.3.2.The Netherlands
11.4.7.3.3.Luxembourg
11.4.8.Rest of Europe
11.4.8.1.Rest of Europe Antacids Market Revenue (US$ Mn) and Forecasts, By Type
11.4.8.1.1.Tablet
11.4.8.1.2.Liquid
11.4.8.1.3.Others
11.4.8.2.Rest of Europe Antacids Market Revenue (US$ Mn) and Forecasts, By End-use
11.4.8.2.1.Hospital Pharmacy
11.4.8.2.2.Retail Pharmacy
11.4.8.2.3.Online Pharmacy
11.5.Key Segment for Channeling Investments
11.5.1.By Country
11.5.2.By Type
11.5.3.By End-use
12.Asia Pacific Antacids Market Analysis and Forecasts, 2023 – 2031
12.1.Overview
12.1.1.Asia Pacific Antacids Market Revenue (US$ Mn)
12.2.Asia Pacific Antacids Market Revenue (US$ Mn) and Forecasts, By Type
12.2.1.Tablet
12.2.2.Liquid
12.2.3.Others
12.3.Asia Pacific Antacids Market Revenue (US$ Mn) and Forecasts, By End-use
12.3.1.Hospital Pharmacy
12.3.2.Retail Pharmacy
12.3.3.Online Pharmacy
12.4.Asia Pacific Antacids Market Revenue (US$ Mn) and Forecasts, By Country
12.4.1.China
12.4.1.1.China Antacids Market Revenue (US$ Mn) and Forecasts, By Type
12.4.1.1.1.Tablet
12.4.1.1.2.Liquid
12.4.1.1.3.Others
12.4.1.2.China Antacids Market Revenue (US$ Mn) and Forecasts, By End-use
12.4.1.2.1.Hospital Pharmacy
12.4.1.2.2.Retail Pharmacy
12.4.1.2.3.Online Pharmacy
12.4.2.Japan
12.4.2.1.Japan Antacids Market Revenue (US$ Mn) and Forecasts, By Type
12.4.2.1.1.Tablet
12.4.2.1.2.Liquid
12.4.2.1.3.Others
12.4.2.2.Japan Antacids Market Revenue (US$ Mn) and Forecasts, By End-use
12.4.2.2.1.Hospital Pharmacy
12.4.2.2.2.Retail Pharmacy
12.4.2.2.3.Online Pharmacy
12.4.3.India
12.4.3.1.India Antacids Market Revenue (US$ Mn) and Forecasts, By Type
12.4.3.1.1.Tablet
12.4.3.1.2.Liquid
12.4.3.1.3.Others
12.4.3.2.India Antacids Market Revenue (US$ Mn) and Forecasts, By End-use
12.4.3.2.1.Hospital Pharmacy
12.4.3.2.2.Retail Pharmacy
12.4.3.2.3.Online Pharmacy
12.4.4.New Zealand
12.4.4.1.New Zealand Antacids Market Revenue (US$ Mn) and Forecasts, By Type
12.4.4.1.1.Tablet
12.4.4.1.2.Liquid
12.4.4.1.3.Others
12.4.4.2.New Zealand Antacids Market Revenue (US$ Mn) and Forecasts, By End-use
12.4.4.2.1.Hospital Pharmacy
12.4.4.2.2.Retail Pharmacy
12.4.4.2.3.Online Pharmacy
12.4.5.Australia
12.4.5.1.Australia Antacids Market Revenue (US$ Mn) and Forecasts, By Type
12.4.5.1.1.Tablet
12.4.5.1.2.Liquid
12.4.5.1.3.Others
12.4.5.2.Australia Antacids Market Revenue (US$ Mn) and Forecasts, By End-use
12.4.5.2.1.Hospital Pharmacy
12.4.5.2.2.Retail Pharmacy
12.4.5.2.3.Online Pharmacy
12.4.6.South Korea
12.4.6.1.South Korea Antacids Market Revenue (US$ Mn) and Forecasts, By Type
12.4.6.1.1.Tablet
12.4.6.1.2.Liquid
12.4.6.1.3.Others
12.4.6.2.South Korea Antacids Market Revenue (US$ Mn) and Forecasts, By End-use
12.4.6.2.1.Hospital Pharmacy
12.4.6.2.2.Retail Pharmacy
12.4.6.2.3.Online Pharmacy
12.4.7.Southeast Asia
12.4.7.1.Southeast Asia Antacids Market Revenue (US$ Mn) and Forecasts, By Type
12.4.7.1.1.Tablet
12.4.7.1.2.Liquid
12.4.7.1.3.Others
12.4.7.2.Southeast Asia Antacids Market Revenue (US$ Mn) and Forecasts, By End-use
12.4.7.2.1.Hospital Pharmacy
12.4.7.2.2.Retail Pharmacy
12.4.7.2.3.Online Pharmacy
12.4.7.3.Southeast Asia Antacids Market Revenue (US$ Mn) and Forecasts, By Country
12.4.7.3.1.Indonesia
12.4.7.3.2.Thailand
12.4.7.3.3.Malaysia
12.4.7.3.4.Singapore
12.4.7.3.5.Rest of Southeast Asia
12.4.8.Rest of Asia Pacific
12.4.8.1.Rest of Asia Pacific Antacids Market Revenue (US$ Mn) and Forecasts, By Type
12.4.8.1.1.Tablet
12.4.8.1.2.Liquid
12.4.8.1.3.Others
12.4.8.2.Rest of Asia Pacific Antacids Market Revenue (US$ Mn) and Forecasts, By End-use
12.4.8.2.1.Hospital Pharmacy
12.4.8.2.2.Retail Pharmacy
12.4.8.2.3.Online Pharmacy
12.5.Key Segment for Channeling Investments
12.5.1.By Country
12.5.2.By Type
12.5.3.By End-use
13.Middle East and Africa Antacids Market Analysis and Forecasts, 2023 – 2031
13.1.Overview
13.1.1.Middle East and Africa Antacids Market Revenue (US$ Mn)
13.2.Middle East and Africa Antacids Market Revenue (US$ Mn) and Forecasts, By Type
13.2.1.Tablet
13.2.2.Liquid
13.2.3.Others
13.3.Middle East and Africa Antacids Market Revenue (US$ Mn) and Forecasts, By End-use
13.3.1.Hospital Pharmacy
13.3.2.Retail Pharmacy
13.3.3.Online Pharmacy
13.4.Middle East and Africa Antacids Market Revenue (US$ Mn) and Forecasts, By Country
13.4.1.Saudi Arabia
13.4.1.1.Saudi Arabia Antacids Market Revenue (US$ Mn) and Forecasts, By Type
13.4.1.1.1.Tablet
13.4.1.1.2.Liquid
13.4.1.1.3.Others
13.4.1.2.Saudi Arabia Antacids Market Revenue (US$ Mn) and Forecasts, By End-use
13.4.1.2.1.Hospital Pharmacy
13.4.1.2.2.Retail Pharmacy
13.4.1.2.3.Online Pharmacy
13.4.2.UAE
13.4.2.1.UAE Antacids Market Revenue (US$ Mn) and Forecasts, By Type
13.4.2.1.1.Tablet
13.4.2.1.2.Liquid
13.4.2.1.3.Others
13.4.2.2.UAE Antacids Market Revenue (US$ Mn) and Forecasts, By End-use
13.4.2.2.1.Hospital Pharmacy
13.4.2.2.2.Retail Pharmacy
13.4.2.2.3.Online Pharmacy
13.4.3.Egypt
13.4.3.1.Egypt Antacids Market Revenue (US$ Mn) and Forecasts, By Type
13.4.3.1.1.Tablet
13.4.3.1.2.Liquid
13.4.3.1.3.Others
13.4.3.2.Egypt Antacids Market Revenue (US$ Mn) and Forecasts, By End-use
13.4.3.2.1.Hospital Pharmacy
13.4.3.2.2.Retail Pharmacy
13.4.3.2.3.Online Pharmacy
13.4.4.Kuwait
13.4.4.1.Kuwait Antacids Market Revenue (US$ Mn) and Forecasts, By Type
13.4.4.1.1.Tablet
13.4.4.1.2.Liquid
13.4.4.1.3.Others
13.4.4.2.Kuwait Antacids Market Revenue (US$ Mn) and Forecasts, By End-use
13.4.4.2.1.Hospital Pharmacy
13.4.4.2.2.Retail Pharmacy
13.4.4.2.3.Online Pharmacy
13.4.5.South Africa
13.4.5.1.South Africa Antacids Market Revenue (US$ Mn) and Forecasts, By Type
13.4.5.1.1.Tablet
13.4.5.1.2.Liquid
13.4.5.1.3.Others
13.4.5.2.South Africa Antacids Market Revenue (US$ Mn) and Forecasts, By End-use
13.4.5.2.1.Hospital Pharmacy
13.4.5.2.2.Retail Pharmacy
13.4.5.2.3.Online Pharmacy
13.4.6.Rest of Middle East & Africa
13.4.6.1.Rest of Middle East & Africa Antacids Market Revenue (US$ Mn) and Forecasts, By Type
13.4.6.1.1.Tablet
13.4.6.1.2.Liquid
13.4.6.1.3.Others
13.4.6.2.Rest of Middle East & Africa Antacids Market Revenue (US$ Mn) and Forecasts, By End-use
13.4.6.2.1.Hospital Pharmacy
13.4.6.2.2.Retail Pharmacy
13.4.6.2.3.Online Pharmacy
13.5.Key Segment for Channeling Investments
13.5.1.By Country
13.5.2.By Type
13.5.3.By End-use
14.Latin America Antacids Market Analysis and Forecasts, 2023 – 2031
14.1.Overview
14.1.1.Latin America Antacids Market Revenue (US$ Mn)
14.2.Latin America Antacids Market Revenue (US$ Mn) and Forecasts, By Type
14.2.1.Tablet
14.2.2.Liquid
14.2.3.Others
14.3.Latin America Antacids Market Revenue (US$ Mn) and Forecasts, By End-use
14.3.1.Hospital Pharmacy
14.3.2.Retail Pharmacy
14.3.3.Online Pharmacy
14.4.Latin America Antacids Market Revenue (US$ Mn) and Forecasts, By Country
14.4.1.Brazil
14.4.1.1.Brazil Antacids Market Revenue (US$ Mn) and Forecasts, By Type
14.4.1.1.1.Tablet
14.4.1.1.2.Liquid
14.4.1.1.3.Others
14.4.1.2.Brazil Antacids Market Revenue (US$ Mn) and Forecasts, By End-use
14.4.1.2.1.Hospital Pharmacy
14.4.1.2.2.Retail Pharmacy
14.4.1.2.3.Online Pharmacy
14.4.2.Argentina
14.4.2.1.Argentina Antacids Market Revenue (US$ Mn) and Forecasts, By Type
14.4.2.1.1.Tablet
14.4.2.1.2.Liquid
14.4.2.1.3.Others
14.4.2.2.Argentina Antacids Market Revenue (US$ Mn) and Forecasts, By End-use
14.4.2.2.1.Hospital Pharmacy
14.4.2.2.2.Retail Pharmacy
14.4.2.2.3.Online Pharmacy
14.4.3.Rest of Latin America
14.4.3.1.Rest of Latin America Antacids Market Revenue (US$ Mn) and Forecasts, By Type
14.4.3.1.1.Tablet
14.4.3.1.2.Liquid
14.4.3.1.3.Others
14.4.3.2.Rest of Latin America Antacids Market Revenue (US$ Mn) and Forecasts, By End-use
14.4.3.2.1.Hospital Pharmacy
14.4.3.2.2.Retail Pharmacy
14.4.3.2.3.Online Pharmacy
14.5.Key Segment for Channeling Investments
14.5.1.By Country
14.5.2.By Type
14.5.3.By End-use
15.Competitive Benchmarking
15.1.Market Share Analysis, 2022
15.2.Global Presence and Growth Strategies
15.2.1.Mergers and Acquisitions
15.2.2.Product Launches
15.2.3.Investments Trends
15.2.4.R&D Initiatives
16.Player Profiles
16.1.Bayer AG
16.1.1.Company Details
16.1.2.Company Overview
16.1.3.Product Offerings
16.1.4.Key Developments
16.1.5.Financial Analysis
16.1.6.SWOT Analysis
16.1.7.Business Strategies
16.2.Boehringer Ingelheim International GmbH
16.2.1.Company Details
16.2.2.Company Overview
16.2.3.Product Offerings
16.2.4.Key Developments
16.2.5.Financial Analysis
16.2.6.SWOT Analysis
16.2.7.Business Strategies
16.3.Dr. Reddy’s Laboratories Ltd.
16.3.1.Company Details
16.3.2.Company Overview
16.3.3.Product Offerings
16.3.4.Key Developments
16.3.5.Financial Analysis
16.3.6.SWOT Analysis
16.3.7.Business Strategies
16.4.GSK plc
16.4.1.Company Details
16.4.2.Company Overview
16.4.3.Product Offerings
16.4.4.Key Developments
16.4.5.Financial Analysis
16.4.6.SWOT Analysis
16.4.7.Business Strategies
16.5.Pfizer Inc.
16.5.1.Company Details
16.5.2.Company Overview
16.5.3.Product Offerings
16.5.4.Key Developments
16.5.5.Financial Analysis
16.5.6.SWOT Analysis
16.5.7.Business Strategies
16.6.Procter & Gamble
16.6.1.Company Details
16.6.2.Company Overview
16.6.3.Product Offerings
16.6.4.Key Developments
16.6.5.Financial Analysis
16.6.6.SWOT Analysis
16.6.7.Business Strategies
16.7.Reckitt Benckiser Group PLC
16.7.1.Company Details
16.7.2.Company Overview
16.7.3.Product Offerings
16.7.4.Key Developments
16.7.5.Financial Analysis
16.7.6.SWOT Analysis
16.7.7.Business Strategies
16.8.Sanofi
16.8.1.Company Details
16.8.2.Company Overview
16.8.3.Product Offerings
16.8.4.Key Developments
16.8.5.Financial Analysis
16.8.6.SWOT Analysis
16.8.7.Business Strategies
16.9.Sun Pharmaceutical Industries Ltd.
16.9.1.Company Details
16.9.2.Company Overview
16.9.3.Product Offerings
16.9.4.Key Developments
16.9.5.Financial Analysis
16.9.6.SWOT Analysis
16.9.7.Business Strategies
16.10.Takeda Pharmaceutical Company Limited
16.10.1.Company Details
16.10.2.Company Overview
16.10.3.Product Offerings
16.10.4.Key Developments
16.10.5.Financial Analysis
16.10.6.SWOT Analysis
16.10.7.Business Strategies
16.11.Other Market Participants
17.Key Findings

.

Note: This ToC is tentative and can be changed according to the research study conducted during the course of report completion

**Exclusive for Multi-User and Enterprise User.

Global Antacids Market

By Type

  • Tablet
  • Liquid
  • Others

By End-use

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

By Region

  • North America (U.S., Canada, Mexico, Rest of North America)
  • Europe (France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe)
  • Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific)
  • Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa)
  • Latin America (Brazil, Argentina, Rest of Latin America)

 

Note: This ToC is tentative and can be changed according to the research study conducted during the course of report completion

**Exclusive for Multi-User and Enterprise User.

The Niche Research approach encompasses both primary and secondary research methods to provide comprehensive insights. While primary research is the cornerstone of our studies, we also incorporate secondary research sources such as company annual reports, premium industry databases, press releases, industry journals, and white papers.

Within our primary research, we actively engage with various industry stakeholders, conducting paid interviews and surveys. Our meticulous analysis extends to every market participant in major countries, allowing us to thoroughly examine their portfolios, calculate market shares, and segment revenues.

Our data collection primarily focuses on individual countries within our research scope, enabling us to estimate regional market sizes. Typically, we employ a bottom-up approach, meticulously tracking trends in different countries. We analyze growth drivers, constraints, technological innovations, and opportunities for each country, ultimately arriving at regional figures.Our process begins by examining the growth prospects of each country. Building upon these insights, we project growth and trends for the entire region. Finally, we utilize our proprietary model to refine estimations and forecasts.

Our data validation standards are integral to ensuring the reliability and accuracy of our research findings. Here’s a breakdown of our data validation processes and the stakeholders we engage with during our primary research:

  • Supply Side Analysis: We initiate a supply side analysis by directly contacting market participants, through telephonic interviews and questionnaires containing both open-ended and close-ended questions. We gather information on their portfolios, segment revenues, developments, and growth strategies.
  • Demand Side Analysis: To gain insights into adoption trends and consumer preferences, we reach out to target customers and users (non-vendors). This information forms a vital part of the qualitative analysis section of our reports, covering market dynamics, adoption trends, consumer behavior, spending patterns, and other related aspects.
  • Consultant Insights: We tap into the expertise of our partner consultants from around the world to obtain their unique viewpoints and perspectives. Their insights contribute to a well-rounded understanding of the markets under investigation.
  • In-House Validation: To ensure data accuracy and reliability, we conduct cross-validation of data points and information through our in-house team of consultants and utilize advanced data modeling tools for thorough verification.

The forecasts we provide are based on a comprehensive assessment of various factors, including:

  • Market Trends and Past Performance (Last Five Years): We accurately analyze market trends and performance data from preceding five years to identify historical patterns and understand the market’s evolution.
  • Historical Performance and Growth of Market Participants: We assess the historical performance and growth trajectories of key market participants. This analysis provides insights into the competitive landscape and individual company strategies.
  • Market Determinants Impact Analysis (Next Eight Years): We conduct a rigorous analysis of the factors that are projected to influence the market over the next eight years. This includes assessing both internal and external determinants that can shape market dynamics.
  • Drivers and Challenges for the Forecast Period:Identify the factors expected to drive market growth during the forecast period, as well as the challenges that the industry may face. This analysis aids in deriving an accurate growth rate projection.
  • New Acquisitions, Collaborations, or Partnerships: We keep a close watch on any new acquisitions, collaborations, or partnerships within the industry. These developments can have a significant impact on market dynamics and competitiveness.
  • Macro and Micro Factors Analysis:A thorough examination of both macro-level factors (e.g., economic trends, regulatory changes) and micro-level factors (e.g., technological advancements, consumer preferences) that may influence the market during the forecast period.
  • End-User Sentiment Analysis: To understand the market from the end-user perspective, we conduct sentiment analysis. This involves assessing the sentiment, preferences, and feedback of the end-users, which can provide valuable insights into market trends.
  • Perspective of Primary Participants: Insights gathered directly from primary research participants play a crucial role in shaping our forecasts. Their perspectives and experiences provide valuable qualitative data.
  • Year-on-Year Growth Trend: We utilize a year-on-year growth trend based on historical market growth and expected future trends. This helps in formulating our growth projections, aligning them with the market’s historical performance.

Research process adopted by TNR involves multiple stages, including data collection, validation, quality checks, and presentation. It’s crucial that the data and information we provide add value to your existing market understanding and expertise. We have also established partnerships with business consulting, research, and survey organizations across regions and globally to collaborate on regional analysis and data validation, ensuring the highest level of accuracy and reliability in our reports.

 

 

Procure Comprehensive Study of

Global Antacids Market

Online Only

  • Online Access
  • Read Only File
  • Validity 3 Months
  • Print, Copy, Paste & Download
  • PPT, Excel
  • Cost-Free Report in the Next Update
$3300
Buy Now

Single User

  • Access to One User on One System
  • Read Only File
  • Validity 6 Months
  • Limited Print,Copy, Paste
  • PPT, Excel
  • Cost-Free Report in the Next Update
$4200
Buy Now

Multi User

  • Access to Fiver Users
  • PDF File
  • Validity 1 Year
  • Upto FivePrints
  • Cost-Free Report in the Next Update
  • PPT, Excel
$6000
Buy Now

Enterprise User

  • Access to Unlimited Users
  • PDF, PPT, Excel
  • Unlimited Validity, Prints&Downloads
  • 1 Hour Cost-Free & Dedicated Analyst Support
  • 10% Cost-Free Customization
  • Cost-Free Report Update Twice in a Year
  • Recommendations for Business Strategies
  • Authorization to Quote TNR, The Niche Research
$7300
Buy Now

Library Access

  • Online Access to Content Publications
  • Access Player Profiles Online
  • Get Immediate Access to Newly Added Content
  • Acquire 12 PDF Downloads
  • Acquire 5 Excel Data Sets
  • Gain Access to 290+ PDFs of Company Profiles
  • Round-the-clock Email and Phone Assistance
  • Dashboard Usage and Trends
  • Renewal & Upgrade Assistance
  • Assessing Customization Options and Alerts for New Reports
$10788
Buy Now
*Taxes/Fees, if applicable will be added during checkout. All prices in USD

Why TNR The Niche Research?

  • Unwavering Commitment to Excellence

  • Veteran Team of Researchers

  • Accurate and Timely Insights

  • Ethical Practices and Customized Service

  • Uninterrupted Availability Around the Clock

Scroll to Top